highli
pathogen
influenza
virus
continu
caus
seriou
threat
public
health
due
pandem
potenti
call
urgent
need
develop
effect
safe
conveni
univers
vaccin
influenza
viru
infect
studi
construct
two
recombin
protein
vaccin
hereinaft
hereinaft
respect
link
highli
conserv
sequenc
two
molecul
ectodomain
one
molecul
fusion
peptid
fp
epitop
hemagglutinin
ha
influenza
virus
differ
order
escherichia
coliexpress
protein
induc
similarli
hightit
antibodi
immun
mice
importantli
protein
abl
prevent
lethal
challeng
heterolog
influenza
viru
significantli
reduc
viral
titer
allevi
patholog
chang
lung
well
increas
bodi
weight
complet
surviv
challeng
mice
taken
togeth
studi
demonstr
highli
conserv
fp
epitop
ha
influenza
virus
use
import
target
develop
safe
econom
univers
influenza
vaccin
posit
ha
epitop
sequenc
vaccin
compon
signific
effect
immunogen
efficaci
subunit
vaccin
abbrevi
cpe
cytopath
effect
hafp
hemagglutinin
fusion
peptid
iptg
isopropylbdthiogalactopyranosid
extracellular
domain
tcid
tissu
cultur
infecti
dose
highli
conserv
hemagglutinin
epitopebas
recombin
protein
induc
protect
influenza
viru
infect
influenza
one
import
emerg
infecti
diseas
threaten
public
health
worldwid
influenza
vaccin
requir
annual
immun
larg
number
peopl
prevent
influenza
highli
pathogen
avian
influenza
virus
well
pandem
influenza
viru
infect
human
caus
sporad
case
epidem
call
continu
effort
develop
vaccin
prevent
threat
influenza
current
influenza
vaccin
mainli
strainspecif
target
one
close
relat
strain
limit
efficaci
prevent
diverg
new
viral
strain
thu
develop
effect
univers
vaccin
crossprotect
efficaci
variant
influenza
virus
focu
influenza
research
extracellular
domain
protein
influenza
viru
highli
conserv
among
influenza
virus
thu
serv
promis
target
develop
univers
influenza
vaccin
howev
contain
amino
acid
molecul
poor
induc
immun
respons
elucid
need
improv
immunogen
design
influenza
vaccin
number
approach
includ
conjug
carrier
protein
neisseria
meningitidi
outer
membran
complex
ompc
bacteri
flagellin
increas
copi
number
molecul
introduc
increas
immunogen
andor
protect
efficaci
vaccin
addit
fusion
peptid
fp
epitop
hemagglutinin
stem
region
influenza
viru
also
highli
conserv
influenza
virus
make
anoth
import
vaccin
target
chimer
vaccin
synthet
peptid
contain
conserv
sequenc
may
induc
crossreact
crossprotect
antibodi
diverg
influenza
virus
constitut
key
approach
develop
univers
influenza
vaccin
studi
design
two
recombin
vaccin
hereinaft
hereinaft
respect
contain
highli
conserv
sequenc
two
molecul
one
hafp
molecul
influenza
virus
two
differ
order
express
protein
escherichia
coli
express
system
evalu
immunogen
crossprotect
efficaci
two
subunit
vaccin
heterolog
strain
influenza
viru
studi
demonstr
posit
ha
epitop
sequenc
vaccin
compon
signific
impact
immunogen
efficaci
subunit
vaccin
suggest
potenti
develop
protein
effect
econom
univers
influenza
vaccin
femal
balbc
mice
week
old
use
studi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
approv
committe
ethic
anim
experi
beij
institut
microbiolog
epidemiolog
permit
number
new
york
blood
center
permit
number
construct
recombin
vaccin
contain
hafp
influenza
virus
carri
previous
describ
briefli
gene
encod
highli
conserv
sequenc
two
molecul
one
molecul
hafp
well
two
molecul
one
molecul
hafp
two
order
synthes
insert
e
coli
express
vector
sequenc
correct
sequenc
linker
sequenc
encod
gggg
ad
molecul
tag
ad
cterminu
easi
purif
express
recombin
protein
recombin
protein
express
e
coli
express
system
previous
describ
modif
briefli
aforement
recombin
plasmid
encod
protein
transform
e
coli
cultur
lb
medium
overnight
c
dilut
continu
cultur
valu
reach
isopropylbdthiogalactopyranosid
iptg
sigma
ad
final
concentr
mm
e
coli
centrifug
collect
pellet
sonic
e
coli
supernat
contain
express
protein
collect
purifi
use
nichromatographi
promega
gel
filtrat
chromatographi
purifi
recombin
protein
concentr
analyz
endotoxin
use
studi
recombin
protein
analyz
sdspage
western
blot
previous
describ
briefli
iptginduc
protein
noninduc
control
boil
min
separ
triseglycin
gel
stain
coomassi
brilliant
blue
sdspage
analysi
sampl
also
transfer
nitrocellulos
membran
western
blot
analysi
block
blot
use
fatfre
milk
pbst
overnight
c
sequenti
incub
h
room
temperatur
influenza
viru
polyclon
antibodi
laboratori
stock
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antibodi
invitrogen
signal
detect
use
ecl
substrat
buffer
peirc
amersham
hyperfilm
influenza
viru
grown
allanto
caviti
embryon
chicken
egg
viruscontain
allanto
fluid
harvest
h
store
c
use
mice
immun
recombin
protein
challeng
influenza
viru
use
previous
describ
protocol
modif
briefli
balbc
mice
intramuscularli
im
immun
mlmous
presenc
aluminum
adjuv
boost
twice
interv
mice
inject
pb
plu
adjuv
includ
neg
control
sera
collect
vaccin
measur
influenza
viru
igg
antibodi
one
month
postlast
immun
mice
challeng
influenza
viru
tissu
cultur
infecti
dose
tcid
infect
mice
detect
patholog
chang
h
e
stain
viral
titer
lung
tissu
day
postinfect
pi
observ
surviv
weight
chang
day
pi
elisa
use
analyz
influenza
viru
antibodi
respons
immun
mous
sera
previous
describ
modif
briefli
elisa
plate
coat
recombin
protein
overnight
c
block
bsapb
h
c
mous
sera
dilut
ad
plate
incub
h
c
wash
plate
incub
hrpconjug
antimous
igg
antimous
antimous
santa
cruz
respect
h
c
reaction
detect
tmb
substrat
invitrogen
stop
n
h
absorb
nm
measur
use
elisa
plate
reader
relat
antibodi
titer
calcul
viral
titer
lung
tissu
challeng
mice
detect
previous
describ
modif
briefli
lung
tissu
homogen
minim
essenti
medium
mem
achiev
wv
suspens
serial
dilut
sampl
ad
monolay
madinedarbi
canin
kidney
mdck
cell
seed
tissu
cultur
plate
incub
h
c
supernat
remov
replac
fresh
mem
follow
incub
mdck
cell
h
viral
cytopath
effect
cpe
observ
daili
viral
titer
calcul
ha
test
ha
test
ml
turkey
red
blood
cell
lampir
biolog
laboratori
ad
ml
cell
cultur
supernat
incub
room
temperatur
min
well
contain
ha
score
posit
viral
titer
calcul
reed
muench
method
express
log
tcid
g
lung
tissu
valu
present
mean
standard
deviat
sd
statist
signific
calcul
student
ttest
use
graphpad
prism
statist
softwar
indic
p
amino
acid
sequenc
hafp
influenza
virus
highli
conserv
among
influenza
virus
maintain
least
homolog
construct
two
recombin
protein
design
respect
link
two
molecul
one
fp
epitop
ha
protein
influenza
virus
differ
order
fig
express
fusion
protein
e
coli
express
system
conveni
econom
system
express
recombin
protein
manufactur
capac
protein
expect
molecular
weight
size
express
solubl
form
induc
e
coli
fig
left
purifi
puriti
recogn
monoclon
antibodi
develop
laboratori
band
detect
noninduc
cell
control
fig
middl
purifi
protein
use
coat
antigen
detect
reactiv
sera
mice
immun
fp
peptid
influenza
viru
result
show
recombin
protein
react
specif
respect
sera
control
sera
fig
right
data
suggest
construct
hafp
fusion
protein
success
express
maintain
strong
specif
influenza
viru
evalu
immunogen
hafp
fusion
protein
immun
mice
use
two
protein
follow
protocol
describ
materi
method
detect
result
antibodi
respons
mous
sera
shown
fig
protein
abl
elicit
similarli
level
potent
igg
antibodi
increas
higher
titer
boost
maintain
least
week
detect
period
wherea
background
level
antibodi
detect
sera
control
mice
evalu
antibodi
subtyp
reveal
high
titer
particularli
antibodi
induc
sera
proteinimmun
mice
collect
week
postimmun
control
mice
inject
pb
fig
result
indic
maintain
strong
immunogen
induc
longterm
specif
antibodi
fusion
protein
elicit
rel
higher
titer
bias
antibodi
respons
thu
potenti
promot
product
antibodymedi
humor
immun
respons
confirm
immunogen
fusion
protein
next
investig
protect
immun
challeng
immun
mice
heterolog
strain
influenza
viru
detect
viral
replic
patholog
damag
lung
day
postinfect
expect
mice
immun
two
fusion
protein
significantli
lower
titer
viru
lung
control
mice
receiv
pb
fig
analysi
patholog
chang
demonstr
fusion
protein
effect
protect
mice
infect
obvious
allevi
lung
damag
presenc
balt
bronchusassoci
lymphoid
tissu
surround
lung
bronchial
tube
fig
left
middl
characterist
help
restor
lung
tissu
cell
contrast
seriou
mesenchym
inflamm
lung
tissu
control
mice
repres
thicken
alveolar
wall
inflammatori
cell
infiltr
hemorrhag
vessel
inflamm
fig
right
data
suggest
two
fusion
protein
strong
abil
inhibit
viral
replic
reduc
viruscaus
tissu
damag
protect
efficaci
fusion
protein
evalu
challeng
immun
mice
result
demonstr
significantli
prevent
weight
loss
mice
viral
challeng
slightli
reduc
weight
day
steadili
increas
weight
day
postinfect
comparison
control
mice
continu
weight
loss
fig
addit
mice
immun
two
fusion
protein
surviv
influenza
viru
challeng
end
detect
period
wherea
none
control
mice
inject
pb
surviv
challeng
die
day
postinfect
fig
result
confirm
protect
efficaci
test
influenza
vaccin
provid
complet
protect
infect
heterolog
strain
influenza
viru
suggest
posit
hafp
epitop
sequenc
subunit
vaccin
signific
impact
protect
highli
conserv
influenza
viru
fp
use
effect
vaccin
target
develop
univers
influenza
vaccin
broad
protect
efficaci
prevent
diverg
viral
strain
inde
previous
indic
tetrabranch
multipl
antigen
peptid
map
base
vaccin
carri
four
copi
peptid
confer
crossprotect
lethal
infect
two
clade
one
pandem
influenza
virus
also
demonstr
abil
recombin
fusion
protein
contain
three
conserv
molecul
new
onchocerca
volvulu
activ
associ
adjuv
crossprotect
two
diverg
strain
influenza
virus
addit
peptidebas
vaccin
develop
test
crossprotect
infect
new
viru
vaccin
provid
potent
crossprotect
lethal
challeng
viru
studi
design
two
recombin
univers
influenza
vaccin
respect
link
two
molecul
one
molecul
hafp
sequenc
two
differ
order
evalu
immunogen
protect
heterolog
strain
sequenc
hafp
use
studi
highli
conserv
among
influenza
viru
strain
maintain
homolog
expect
protein
link
two
differ
order
fp
molecul
abl
induc
effect
antibodi
respons
crossprotect
lethal
challeng
influenza
viru
surviv
rate
indic
hafp
recombin
proteinbas
univers
vaccin
capac
elicit
suffici
crossprotect
efficaci
infect
heterolog
strain
influenza
viru
also
found
two
protein
presenc
aluminum
adjuv
elicit
high
titer
antibodi
respons
immun
mice
fail
induc
effect
cellular
immun
respons
data
shown
suggest
hafp
recombin
proteininduc
protect
might
mainli
humor
rather
cellular
immun
responsemedi
immun
studi
shown
mechan
crossprotect
influenza
viru
vaccin
may
antibodydepend
cellmedi
cytotox
adcc
complementdepend
cytolysi
cdc
addit
molecul
recombin
protein
also
contain
hafp
conserv
epitop
sequenc
futur
studi
warrant
elucid
protect
mechan
hafpbas
recombin
vaccin
well
detect
efficaci
protect
multipl
current
futur
strain
influenza
viru
pandem
potenti
overal
studi
suggest
simultan
express
molecul
hafp
peptid
sever
import
influenza
viru
strain
may
help
facilit
develop
univers
vaccin
broadspectrum
crossprotect
efficaci
diverg
heterolog
strain
influenza
virus
order
hafp
vaccin
compon
signific
effect
immunogen
protect
efficaci
data
demonstr
potenti
develop
univers
influenza
vaccin
base
highli
conserv
sequenc
hafp
epitop
influenza
viru
